SERUR: COVID-19 Serological Survey of Staff From the University Reims-Champagne Ardennes

NACompletedINTERVENTIONAL
Enrollment

389

Participants

Timeline

Start Date

November 5, 2020

Primary Completion Date

December 1, 2020

Study Completion Date

March 15, 2021

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

Anti-SARS-CoV2 Serology

"Diagnostic Test: Anti-SARS-CoV2 Serology A blood sample is collected by venipuncture at Day 0. The anti-SARS-CoV2 serological status is measured by with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays (EUROBIO®)~Other: Questionnaire~Data concerning personal exposure factors are collected in a questionnaire:~* Socio-demographic factors: sex, age,~* known risk-factor for Covid-19~* Professional factors: Employment (type, work time, location), protective measures put in place to reduce the risk of contamination~* Non-professional factors: Contact with infected individuals, carrying of protective equipment and compliance with barrier measures, transport and accomodation modalities during holidays"

Trial Locations (1)

Unknown

Université de Reims Champagne-Ardenne, Reims

All Listed Sponsors
lead

Université de Reims Champagne-Ardenne

OTHER

NCT04816084 - SERUR: COVID-19 Serological Survey of Staff From the University Reims-Champagne Ardennes | Biotech Hunter | Biotech Hunter